1. To understand some of the benefits and disadvantages to current treatment regimens used for induction and maintenance of ANCA vasculitis

2. To learn about new therapeutic targets and drugs in AAV that may reduce morbidity and mortality from the disease and its treatment

Session date: 
12/21/2016 - 4:00pm to 5:00pm CST
UCMC S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Anisha Dua